This book of essays on the first generation of protein drugs made by recombinant protein synthesis is a fascinating melange of gossip science history and opinion covering the 20 or so years since human insulin was first introduced. Recombinant protein drugs have accounted for about 10 of the global prescription drug market the market development was rapid especially in the 21st century which could be called the golden age the sale reached 47 billion in1989 285 billion in 2001 347 billion in 2004 about 41 billion in 2005 and more than 100 billion in 2011 which . Eloctate with fc fusion protein is a naturally occurring protein in the blood that helps blood to clot a lack of antihemophilic factor viii is the cause of hemophilia a recombinant this medicine works by temporarily raising levels of factor viii in the blood to aid in clotting. Study 29 recombinant protein drugs7 flashcards on studyblue third generation no human or animal proteins used in culture or manufacturing process. As drugs with high earning potential they send an important message for pharma companies to consider and it seems they got the message all big pharma now develop and sell recombinant proteins as drugs the ability to develop new recombinant proteins in new indications has resulted in a significant development in major pharma companies
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.